PebbleAtlas
PEBBLE / ATLAS
Open research access
PRECLINICAL PUBLICATION · 2018

Lam. Decreases Oxidative Stress in Blood Cells and Prevents Doxorubicin-Induced Cardiotoxicity.

Mixed / Chemical/toxin

Evidence by therapy association

Study details and outcomes are extracted in the context of a specific intervention. Separate associations are retained rather than silently merged.

PMID 30050650 ↗2018Reported benefit

Lam. Decreases Oxidative Stress in Blood Cells and Prevents Doxorubicin-Induced Cardiotoxicity.

MixedChemical/toxinC57BL/6Male (cardiotoxicity study); female (acute toxicity study)n = n=5 per group (control, doxorubicin, doxorubicin plus GUEsb…Oral200 mg/kg body mass in the cardioprotection study; 2000 and…Extract started at the beginning of the experiment, 6 days before the first dox…

Model: Doxorubicin-induced cardiotoxicity, cumulative 24 mg/kg intraperitoneally divided into six alternate-day doses on days 7, 9, 11, 13, 15 and 17, euthanasia on day 18

Doxorubicin raised cardiac malondialdehyde by about 48 per cent versus control, and co-treatment with 200 mg/kg oral GUEsb prevented this rise, giving malondialdehyde 19 per cent below control. The extract showed no acute toxicity at 2000 or 5000 mg/kg apart from raised creatinine at the highest do…

Extraction: extract · Supplied extraction confidence: 0.85. Machine-extracted fields require source verification.